High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children

Area of Science:

• Pediatric Hematology/Oncology
• Pulmonology
• Transplantation Medicine

Background:

• Bronchiolitis obliterans (BO) is a severe complication following pediatric allogeneic bone marrow transplantation (BMT).
• Current therapeutic interventions lack definitive evidence of efficacy in managing BO post-BMT.

Purpose of the Study:

• To evaluate the effectiveness of high-dose pulse methylprednisolone therapy in pediatric patients diagnosed with BO after BMT.
• To assess the impact of this anti-inflammatory treatment on respiratory function and clinical outcomes.

Main Methods:

• Retrospective analysis of nine pediatric patients with clinical and radiological signs of BO post-BMT.
• Treatment involved 1-6 cycles of high-dose pulse methylprednisolone.
• Assessment of oxygen saturation and forced expiratory volume in 1 second (FEV1) before, during, and after therapy.

Main Results:

• Significant improvement in oxygen saturation, normalizing in all patients by therapy completion.
• Sustained normal oxygen saturation in 8/9 patients during a mean follow-up of 42 months.
• Stabilization of lung function with significant FEV1 improvement at 2 months post-treatment.
• 7/9 patients maintained clinical stability without further lung function decline.

Conclusions:

• High-dose pulse methylprednisolone therapy appears to be a valuable treatment option for pediatric patients with bronchiolitis obliterans post-BMT.
• Anti-inflammatory treatment may help stabilize lung function and improve outcomes in this patient population.